14 julio 2015
A new study has found that it would be cost-effective to treat 48-67 percent of all adults aged 40-75 in the US with cholesterol-lowering statins. By expanding the current recommended treatment guidelines and boosting the percentage of adults taking statins, an additional 161,560 cardiovascular-related events could be averted, according to the researchers.img src=»http://feeds.feedburner.com/~r/sciencedaily/~4/5KWJU2F_awI» height=»1″ width=»1″ alt=»»/
http://feeds.sciencedaily.com/~r/sciencedaily/~3/5KWJU2F_awI/150714124901.htm
